Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK
Cisatracurium 2 mg/ml Solution for Injection/Infusion.
| Pharmaceutical Form |
|---|
|
Solution for injection/infusion. Colourless to pale yellow or greenish yellow solution. pH: 3.0-3.7 Osmolarity: 8 mOsmol/l |
Cisatracurium 2 mg as cisatracurium besilate 2.7 mg per 1 ml.
One vial of 2.5 ml contains 5 mg of cisatracurium as cisatracurium besilate 6.7 mg.
One vial of 5 ml contains 10 mg of cisatracurium as cisatracurium besilate 13.4 mg.
One vial of 10 ml contains 20 mg of cisatracurium as cisatracurium besilate 26.8 mg.
For the full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Cisatracurium is an intermediate-duration, non-depolarising benzylisoquinolinium skeletal muscle relaxant. Cisatracurium binds to cholinergic receptors on the motor end-plate to antagonise the action of acetylcholine, resulting in a competitive block of neuromuscular transmission. This action is readily reversed by anti-cholinesterase agents such as neostigmine or edrophonium. |
| List of Excipients |
|---|
|
Benzenesulfonic acid (for pH adjustment) |
Clear Type I glass vials with rubber stopper; packs of 1 and 5 vials.
Not all pack sizes may be marketed.
Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK
PL 04515/0234
Date of first authorisation: 20/10/2011
Date of latest renewal: 22/08/2016
| Drug | Countries | |
|---|---|---|
| CISATRACURIUM | Nigeria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.